← The Wire
CELCNasdaq
Celcuity Inc.
Services-Medical Laboratories · DE · CIK 1603454
Celcuity Inc. develops targeted therapies for solid tumors, focusing on its lead candidate gedatolisib
red 8-K · 90d⚡ Elevated coverage
$4.32B
Market cap
$102.52
Last close
+2.6%
1D
+14.0%
5D
1.0M
Volume
Price · last 39 sessions-29.3%
May 4L $87.32 · H $144.98Jun 29
177
Total filings
Jun 8, 2026
Last filing
12/31
Fiscal year end
8-KMaterial Agreement · Agreement TerminatedJun 8, 2026424B5424B5Jun 5, 2026424B5424B5Jun 3, 20268-KReg FD Disclosure · Company UpdateJun 2, 20268-K/AExecutive ChangeMay 20, 20268-KExecutive Change · Shareholder VoteMay 18, 202610-Q10-QMay 14, 20268-KResults of OperationsMay 14, 20268-KReg FD Disclosure · Company UpdateMay 1, 2026DEFA14ADEFA14AApr 2, 2026DEF 14ADEF 14AApr 2, 202610-K10-KMar 26, 20268-KResults of OperationsMar 25, 2026SC 13D/ASC 13D/AMar 24, 2026SC 13D/ASC 13D/AMar 9, 20268-KExecutive Change · Reg FD DisclosureFeb 12, 2026SC 13D/ASC 13D/AJan 16, 20268-KReg FD Disclosure · Company UpdateNov 17, 202510-Q10-QNov 13, 20258-KResults of OperationsNov 12, 20258-KReg FD Disclosure · Company UpdateOct 20, 20258-KMaterial Agreement · New Debt / ObligationSep 10, 202510-Q10-QAug 14, 20258-KResults of OperationsAug 14, 20258-KMaterial Agreement · New Debt / ObligationAug 1, 20258-KMaterial Agreement · Company UpdateJul 31, 2025424B5424B5Jul 31, 2025424B5424B5Jul 31, 2025424B5424B5Jul 29, 20258-KMaterial Agreement · Company UpdateJul 29, 2025424B5424B5Jul 28, 2025424B5424B5Jul 28, 20258-KReg FD Disclosure · Company UpdateJul 28, 20258-KReg FD Disclosure · Company UpdateJun 30, 20258-KExecutive Change · Shareholder VoteMay 16, 202510-Q10-QMay 15, 20258-KResults of OperationsMay 14, 2025DEFA14ADEFA14AApr 1, 2025DEF 14ADEF 14AApr 1, 202510-K10-KMar 31, 20258-KResults of OperationsMar 31, 20258-KCompany UpdateDec 6, 2024424B5424B5Dec 6, 202410-Q10-QNov 14, 2024SC 13GSC 13GNov 14, 20248-KResults of OperationsNov 14, 20248-KBylaw Amendment · Shareholder VoteOct 9, 2024DEFA14ADEFA14AAug 28, 2024DEF 14ADEF 14AAug 28, 202410-Q10-QAug 14, 20248-KResults of OperationsAug 14, 2024SC 13GTHE SCHEDULE 13GJun 10, 20248-KMaterial Agreement · Company UpdateMay 31, 2024424B5424B5May 30, 20248-KMaterial Agreement · New Debt / ObligationMay 30, 202410-Q10-QMay 15, 20248-KResults of OperationsMay 15, 20248-KExecutive Change · Shareholder VoteMay 13, 20248-KMaterial Agreement · New Debt / ObligationMar 29, 2024DEFA14ADEFA14AMar 28, 2024DEF 14ADEF 14AMar 28, 202410-K10-KMar 27, 20248-KResults of OperationsMar 27, 2024SC 13GSC 13GDec 26, 20238-KCompany UpdateDec 5, 202310-Q10-QNov 13, 20238-KResults of OperationsNov 13, 20238-KMaterial Agreement · Equity IssuanceOct 23, 20238-KExecutive ChangeAug 24, 20238-KCompany UpdateAug 22, 202310-Q10-QAug 11, 20238-KResults of OperationsAug 10, 202310-Q10-QMay 15, 20238-KResults of OperationsMay 15, 20238-KExecutive Change · Shareholder VoteMay 12, 202310-K/A10-K/AApr 7, 2023DEF 14ADEF 14AMar 31, 2023DEFA14ADEFA14AMar 31, 202310-K10-KMar 23, 20238-KResults of OperationsMar 23, 2023
Insider Activity
In the 90 days to Jan 27, 2026: 2 sold $4.7M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 27, 2026 | Dalvey DavidDirector | Sell | 20,000 | $120.03 | $2.4M |
| Dec 5, 2025 | Buller Richard EDirector | Sell | 1,510 | $106.04 | $160K |
| Dec 5, 2025 | Buller Richard EDirector | Sell | 1,490 | $105.34 | $157K |
| Dec 1, 2025 | Buller Richard EDirector | Sell | 1,100 | $98.13 | $108K |
| Nov 21, 2025 | Dalvey DavidDirector | Sell | 15,000 | $100.00 | $1.5M |
| Nov 20, 2025 | Buller Richard EDirector | Sell | 3,900 | $96.73 | $377K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
⚡ Elevated coverageCoverage (30d): 1 reputable article · skews ▲ positive.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance